You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 4,423,050


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 4,423,050
Title: 9-(1,3-Dihydroxy-2-propoxymethyl)guanine as antiviral agent
Abstract:The compound 9-(1,3-dihydroxy-2-propoxymethyl)guanine and the pharmaceutically acceptable salts thereof are useful as antiviral agents.
Inventor(s): Verheyden; Julien P. H. (Los Altos, CA), Martin; John C. (Redwood City, CA)
Assignee: Syntex (U.S.A.) Inc. (Palo Alto, CA)
Application Number:06/380,969
Patent Claim Types:
see list of patent claims
Use; Composition; Compound;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 4,423,050: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the specifics of United States Patent 4,423,050, providing a detailed analysis of its claims, the patent landscape, and relevant legal and practical considerations.

Background of the Patent

United States Patent 4,423,050, issued in 1983, is a utility patent that covers a specific invention. To analyze this patent, one must first identify the invention disclosed and the claims made.

Identifying the Invention

The invention disclosed in the patent is described in the specification section. This section provides a detailed description of the invention, including its components, functionality, and any drawings or diagrams that illustrate the invention.

Understanding Patent Claims

Patent claims are the heart of any patent, as they define the scope of protection granted to the inventor. Claims can be independent or dependent and are categorized into different types such as method claims, apparatus claims, and composition claims.

Independent Claims

Independent claims stand alone and define the invention without reference to other claims. These claims are broad and encompass the core aspects of the invention.

Dependent Claims

Dependent claims refer back to an independent claim and further limit the scope of the invention. They often add specific details or features to the broader independent claims.

Analyzing the Claims of Patent 4,423,050

To analyze the claims of this patent, one would typically follow these steps:

Step 1: Identify the Independent Claims

Review the patent document to identify the independent claims. These claims will provide the broadest definition of the invention.

Step 2: Examine Dependent Claims

Analyze the dependent claims to understand how they narrow down the scope of the independent claims. This helps in identifying specific features or limitations of the invention.

Step 3: Review Claim Language

Carefully review the language used in each claim. Pay attention to terms like "comprising," "consisting of," and "including," as these can significantly affect the scope of the claim.

Patent Landscape and Prior Art

Understanding the patent landscape involves identifying prior art and related patents that may affect the validity or enforceability of the patent.

Using USPTO Resources

The USPTO provides several tools to search for prior art and related patents. The Global Dossier service, for example, allows users to see the patent family for a specific application, including all related applications filed at participating IP Offices[1].

Common Citation Document (CCD)

The Common Citation Document (CCD) application consolidates prior art cited by all participating offices for the family members of a patent application. This tool is invaluable for identifying relevant prior art and understanding how different offices have treated similar inventions[1].

Legal Considerations

Patent Infringement and Litigation

The scope and claims of a patent are critical in patent infringement litigation. The number of patent infringement lawsuits has fluctuated over the years, influenced by changes in patent law such as the Leahy-Smith America Invents Act (AIA)[4].

Reissue and Continuation Applications

If the patent holder seeks to change the scope of the claims after the patent is granted, they must comply with statutory limitations, such as the "original patent" requirement under 35 U.S.C. ยง 251. This requirement ensures that reissue claims are directed to the invention disclosed in the original patent[5].

Practical Considerations

Searching and Analyzing Patents

For a thorough analysis, one should use resources like the USPTO Public Search Facility or Patent and Trademark Resource Centers (PTRCs). These facilities provide access to patent and trademark information in various formats and offer trained staff to assist in search techniques[1].

Economic and Statistical Analysis

The USPTO also provides datasets like the Patent Claims Research Dataset, which contains detailed information on claims from U.S. patents and applications. This dataset can be used to analyze trends and statistics related to patent scope and claims[3].

Key Takeaways

  • Claims Analysis: Understanding the independent and dependent claims is crucial for defining the scope of protection.
  • Prior Art: Identifying prior art using tools like the Global Dossier and CCD is essential for assessing the patent's validity.
  • Legal Considerations: Compliance with statutory requirements, such as the "original patent" requirement, is vital for any post-grant changes.
  • Practical Resources: Utilizing USPTO resources and datasets can enhance the analysis and understanding of the patent landscape.

FAQs

Q1: How do I search for prior art related to a specific patent?

You can use the USPTO's Global Dossier service and the Common Citation Document (CCD) application to search for prior art and related patents[1].

Q2: What is the significance of independent and dependent claims in a patent?

Independent claims define the broadest scope of the invention, while dependent claims narrow down this scope by adding specific features or limitations.

Q3: How can I determine if a patent is still in force?

You can check the patent's status using the USPTO's Patent Assignment Search website or by contacting the USPTO directly[1].

Q4: What are the implications of the Leahy-Smith America Invents Act (AIA) on patent litigation?

The AIA introduced several changes, including limiting the number of defendants in a lawsuit, which has influenced the number and nature of patent infringement lawsuits[4].

Q5: How can I access detailed information on patent claims and scope?

The USPTO's Patent Claims Research Dataset provides detailed information on claims from U.S. patents and applications, which can be used for statistical and trend analysis[3].

Sources

  1. USPTO: Search for patents - USPTO[1]
  2. ACUS: U.S. Patent Small Claims Court[2]
  3. USPTO: Patent Claims Research Dataset[3]
  4. GAO: Assessing Factors That Affect Patent Infringement Litigation[4]
  5. CAFC: In Re FLOAT'N'GRILL LLC[5]

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 4,423,050

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 4,423,050

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 244227 ⤷  Subscribe
Austria 15899 ⤷  Subscribe
Australia 572086 ⤷  Subscribe
Australia 8389282 ⤷  Subscribe
Brazil 8202931 ⤷  Subscribe
Canada 1305139 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.